Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
TYLOSIN (AS TYLOSIN TARTRATE PH. EUR.)
Eurovet Animal Health B.V.
QJ01FA90
TYLOSIN (AS TYLOSIN TARTRATE PH. EUR.)
20 %w/v
Solution for Injection
POM
Bovine, Porcine
Tylosin
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Tylovet 20% w/v Solution for injection for cattle and pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injections contains: Active substance: Tylosin (as tylosin tartrate) 200 mg Excipients: Benzyl alcohol 40 mg For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of infections caused by microorganisms susceptible to tylosin. The spectrum of antimicrobial activity of tylosin includes: _Staphylococcus _spp.; _Streptococcus _spp.; _Corynebacterium _spp.: _Neisseria _spp.; _Flavobacterium_ spp.; _Campylobacter _spp.; _Bacillus anthracis; Moraxella bovis; Clostridium _spp.; _Haemophilus _spp.; _Bordetella_ _bronchiseptica; Spirochaetes_; _Bacteroides _spp.; _Mycoplasma _spp. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance, to any other macrolide antibiotics or to any of the excipients. Do not use in new-born animals. Do not use in equine species. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/12/2016_ _CRN 7025437_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals This product contains benzyl alcohol which has been documented to cause adverse reactions in neonates. For this reason this product should not be used in very young animals. Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be base Read the complete document